02.12.2012 Views

SaO2 x Hb + (0.0036xPaO2) [SaO2 x Hb + (0.0036xPaO2)]

SaO2 x Hb + (0.0036xPaO2) [SaO2 x Hb + (0.0036xPaO2)]

SaO2 x Hb + (0.0036xPaO2) [SaO2 x Hb + (0.0036xPaO2)]

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Practical issues

in ScvO2

monitoring

Prof. Jan Bakker MD PhD

Chair dept of Intensive Care

jan.bakker@erasmusmc.nl

1


Supply-Demand

2


TO 2 = Hb x SaO 2 x CO x ζ

OXYGEN DEMAND OXYGEN SUPPLY

3


Oxygen Extraction Ratio

100 ml O2

50 ml O2

consumption is

25 ml O2

consumption is

25 ml O2

75 ml O2

O2ER = 25%

25 ml O2

O2ER = 50%

4


Oxygen extraction

Decreased DO2

O2ER %

5


ScvO2 - SvO2 monitoring

6


Extraction and Mixed

venous oxygenation

O2ER = CaO2 - CvO2

O2ER =

CaO2

[SaO2 x Hb + (0.0036xPaO2)] - [SvO2 x Hb + (0.0036 x PvO2)]

O2ER ≈ 1 - SvO2

SaO2 x Hb + (0.0036xPaO2)

7


Oxygen extraction

Decreased DO2

Lactate (mmol/L)

6

5

4

3

2

1

0

Therapy Withdrawn in Brain Death Patient

0 10 20 30 40

SvO2 (%)

50 60 70 80

8


Venous oximetry

‣ Understand basic physiology of oxygen demand and supply

‣ Understand compensatory mechanisms when either

changes

‣ What is the incidence of abnormal values

‣ What is the clinical impact of abnormal values

‣ When are abnormal values acceptable and unacceptable

‣ Can you treat abnormal values, by what measures and for

how long to benefit the patient

9


Bracht et al. Crit Care 2007;11:R2

10


Venous oximetry

‣ Understand basic physiology of oxygen demand and supply

‣ Understand compensatory mechanisms when either

changes

‣ What is the incidence of abnormal values

‣ What is the clinical impact of abnormal values

‣ When are abnormal values acceptable and unacceptable

‣ Can you treat abnormal values, by what measures and for

how long to benefit the patient

11


Clinical relevance

60 patients abdominal surgery

Crit Care 2006;10:R158 48 elective surgery, 12 emergency surgery

12


Adequacy of CO

Resuscitation using restoration to normal of

traditional hemodynamics does not restore

parameters associated with adequate global blood

flow and tissue oxygenation

Normal SO2 in the right atrium as a target of

therapy improves outcome

Am J Emerg Med 1996;14(2):218-225 § N Engl J Med 2001;345(19):1368-1377

13


Venous oximetry

‣ Understand basic physiology of oxygen demand and supply

‣ Understand compensatory mechanisms when either

changes

‣ What is the incidence of abnormal values

‣ What is the clinical impact of abnormal values

‣ When are abnormal values acceptable and unacceptable

‣ Can you treat abnormal values, by what measures and for

how long to benefit the patient

14


The New England Journal of Medicine

EARLY GOAL-DIRECTED THERAPY IN THE TREATMENT OF SEVERE SEPSIS

AND SEPTIC SHOCK

EMANUEL

ALEXANDRIA

RIVERS

MUZZIN

, M.D., M.P.H., B

, B.S., BERNHARD

FOR

THE

EARLY

RYANT

KNOBLICH

GOAL

NGUYEN,

M.D., S

, M.D., EDWARD

-DIRECTED

ABSTRACT

Background Goal-directed therapy has been used

for severe sepsis and septic shock in the intensive care

unit. This approach involves adjustments of cardiac

preload, afterload, and contractility to balance oxygen

THERAPY

UZANNE

PETERSON

HAVSTAD

, P

H

COLLABORATIVE

, M.A., J

.D., AND

GROUP*

ULIE

MICHAEL

RESSLER

TOMLANOVICH

, B.S.,

, M.D.,

THE systemic inflammatory response syndrome

can be self-limited or can progress to

severe sepsis and septic shock. 1 Along this

continuum, circulatory abnormalities (intravascular

volume depletion, peripheral vasodilatation,

15


Venous oximetry

‣ Understand basic physiology of oxygen demand and supply

‣ Understand compensatory mechanisms when either

changes

‣ What is the incidence of abnormal values

‣ What is the clinical impact of abnormal values

‣ When are abnormal values acceptable and unacceptable

‣ Can you treat abnormal values, by what measures and for

how long to benefit the patient

16


Treatment of low ScvO2

‣ Goal to treat abnormal ScvO2 is to restore the balance

between oxygen demand and oxygen delivery

‣ Decrease oxygen demand

‣ Mechanical ventilation, analgesia, sedation, antipyretics

‣ Increase oxygen delivery

‣ Increase arterial oxygen content (hemoglobin and oxygen

saturation)

‣ Increase cardiac output (fluids, inotropes, mechanical support)

19


For how long should we

target Scv(v)O2

‣Short duration following admission (4-8 hours)

‣ N Engl J Med 2001;345:1368

‣ BMJ 2004;329:258

‣ Crit Care 2005;9:R678

‣Longer duration following admission (24 hours)

‣ JAMA 1993;270:2699

‣ Anesth Analg 2000;90:1052

20


Low ScvO2

Increase in MAP

MAP 65 MAP 75 MAP 85

DO2 (ml/min.M 2 )** 620±59 670±59 703±74

VO2 (ml/min.M 2 ) 119±12 138±20 153±20

SvO2 (%) 76±3 76±2 70±2

Lactate (mmol/l) 3.1±0.9 2.9±0.8 3.0±0.9

Urinary output (ml) 49±18 56±21 43±13

Cap.flow (ml/min.100g) 6.0±1.6 5.8±1.2 5.3±0.9

RBCvelocity (au) 0.42±0.06 0.44±0.06 0.42±0.06

Pa-rCO2 (mmHg) 13±3 17±3 16±3

LeDoux et al. Crit Care Med 2000;28:2729

21


Do

Nothing

Fluid

respnsiveneess

≥ 70%

yes

no

SvO2

< 70%

comfort

Fluids

Inotropes

SaO2

95-100 %

Hb

>4.3 mmol/l

VO2

< 95%

< 4.3 mmol/l

Pain - Agitation

FiO2

PEEP

Transfusion

Analgesia

Sedation

Tim Jansen: Adapted from: Pinsky - Vincent Crit Care Med 2005;33:1119-1122

22


Low ScvO2

Increase in CO

Effect of low dose dobutamine on ScvO2

23


Hour following

admission 0 2 4 6 8

BP 100/50 109/58 105/44 95/43 100/39

HR 148 148 133 132 143

CVD 11 21 16 17 12

Lactate 4.2 4.5 4.8 3.7 2.2

ScvO2 67% 52% 78% 71% 69%

Fluids (ml) x 1670 2000 575 725

Dobu x 3.2 6.3 11.0 11.0

Norepi x 0.56 0.78 0.69 0.69

NTG x - 1 mg/h 2 mg/h 2 mg/h

24


Conclusions

‣ ScvO2 reflects the balance between oxygen demand and oxygen supply

to the tissues

‣ Restoring the balance between demand and supply is the goal of

treatment in clinically relevant abnormal ScvO2

‣ Abnormal ScvO2 is frequently present on admission and following

initial resuscitation and cannot be predicted from global

hemodynamics

‣ Low ScvO2 is associated with increased morbidity and mortality

‣ Targeting normal ScvO2 is possible and benefits patients

‣ Monitoring ScvO2 should be standard practice in high risk patients

25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!